Alto Neuro (ANRO) - Gross Profit Ratio

Alto Neuroscience, Inc. (ANRO) leads the way in personalized psychiatry, leveraging AI for tailored therapy selection. The current gross margin level on the GURU.Markets terminal line chart contains 0.00, which serves as the current parameter value. The company's growth relies on elite neurobiologists and the development of schizophrenia drugs, whose market success currently depends entirely on FDA approval.
Financial and market metric breakdowns for Alto Neuroscience Inc (ANRO)

Gross margin measures production efficiency by determining the percentage of revenue remaining after deducting direct costs of product creation. By analyzing the gross margin as a share of revenue, an investor assesses the ability of Alto Neuroscience, Inc. (ANRO) to control cost of goods sold amid fierce competition with pharma behemoths, where the success of new psychiatric drugs depends directly on the optimization of development costs.